The University of Kentucky Markey Cancer Center this fall treated the first patient in the country with a novel immunitherapy ...

An increased utilisation of chest x-ray (CXR) in general practice is associated with lung cancer diagnosis at an early stage and improved survival outcomes. Practices with the highest CXR rates are ...

Lung cancer is cancer that starts in your lungs. It is the leading cause of cancer death among men and women. Finding lung cancer early before it spreads improves your chances of beating the disease.

On the heels of two FDA approvals in lung cancer treatments, what innovations are next? As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung ...

Small cell lung cancer (SCLC) is rarer than non-small cell lung cancer (NSCLC) but tends to be more difficult to treat. SCLC can be more resistant and aggressive than other cancers, which can increase ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer. Whether ...

Persistent chest tightness and breathing discomfort, often brushed off as stress, acidity or seasonal asthma, may be early warning signs of lung cancer that patients commonly overlook, warns a leading ...